Your browser doesn't support javascript.
loading
Esophageal and gastric cancer incidence trends in Golestan, Iran: An age-period-cohort analysis 2004 to 2018.
Ghasemi-Kebria, Fatemeh; Semnani, Shahryar; Fazel, Abdolreza; Etemadi, Arash; Amiriani, Taghi; Naeimi-Tabiei, Mohammad; Hasanpour-Heidari, Susan; Salamat, Faezeh; Jafari-Delouie, Nastaran; Sedaghat, SeyyedMehdi; Sadeghzadeh, Hamideh; Akbari, Mahnaz; Mehrjerdian, Mahshid; Weiderpass, Elisabete; Roshandel, Gholamreza; Bray, Freddie; Malekzadeh, Reza.
Afiliación
  • Ghasemi-Kebria F; Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran.
  • Semnani S; Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran.
  • Fazel A; Cancer Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
  • Etemadi A; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
  • Amiriani T; Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran.
  • Naeimi-Tabiei M; Cancer Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
  • Hasanpour-Heidari S; Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran.
  • Salamat F; Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran.
  • Jafari-Delouie N; Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran.
  • Sedaghat S; Deputy of Public Health, Golestan University of Medical Sciences, Gorgan, Iran.
  • Sadeghzadeh H; Deputy of Public Health, Golestan University of Medical Sciences, Gorgan, Iran.
  • Akbari M; Deputy of Treatment, Golestan University of Medical Sciences, Gorgan, Iran.
  • Mehrjerdian M; Department of Pathology, Golestan University of Medical Sciences, Gorgan, Iran.
  • Weiderpass E; Office of the Director, International Agency for Research on Cancer (IARC), Lyon, France.
  • Roshandel G; Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran.
  • Bray F; Cancer Surveillance Branch, International Agency for Research on Cancer (IARC), World Health Organization (WHO), Lyon, France.
  • Malekzadeh R; Digestive Oncology Research Center, Digestive Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Int J Cancer ; 153(1): 73-82, 2023 07 01.
Article en En | MEDLINE | ID: mdl-36943026
ABSTRACT
Golestan province in the northeast of Iran is part of the Asian esophageal cancer belt and is known as a high-risk area for esophageal (EC) and gastric cancers (GC). Data on incident cases of EC and GC during 2004 to 2018 were obtained from the Golestan Population-based Cancer Registry (GPCR). The age-standardized incidence rates (ASRs) were calculated and presented per 100 000 person-years. The estimated annual percentage change (EAPC) with 95% confidence interval (95% CI) were calculated. We also fitted age-period-cohort (APC) models to assess nonlinear period and cohort effects as incidence rate ratios (IRRs). Overall, 3004 new cases of EC (ASR = 15.7) and 3553 cases of GC (ASR = 18.3) were registered in the GPCR. We found significant decreasing trends in incidence rates of EC (EAPC = -5.0; 95% CI -7.8 to -2.2) and less marked nonsignificant trends for GC (EAPC = -1.4; 95% CI -4.0 to 1.4) during 2004 to 2018. There was a strong cohort effect for EC with a consistent decrease in the IRR across successive birth cohorts, starting with the oldest birth cohort (1924; IRR = 1.9 vs the reference birth cohort of 1947) through to the most recent cohort born in 1988 (IRR = 0.1). The marked declines in EC incidence rates in Golestan relate to generational changes in its underlying risk factors. Despite favorable trends, this population remains at high risk of both EC and GC. Further studies are warranted to measure the impact of the major risk factors on incidence with a view to designing effective preventative programs.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans País/Región como asunto: Asia Idioma: En Revista: Int J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Irán

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans País/Región como asunto: Asia Idioma: En Revista: Int J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Irán